Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics


impath inc

Welsh Carson Pays $1.14 Billion To Acquire U.S. Oncology, Inc.

EVEN AS THE LAST ISSUE of THE DARK REPORT was reaching clients with news of Genzyme Corp.’s offer to buy IMPATH Inc., another big oncology deal was announced. On March 22, 2004, Welsh, Carson, Anderson & Stowe announced an offer of $15.05 per …

Read More

Chapter 11 Bankruptcy Filed by IMPATH, Inc.

CEO SUMMARY: To the surprise of very few, IMPATH, Inc. filed for Chapter 11 bankruptcy protection. During 2003, most of IMPATH’s key executives departed as different problems within the company became known. IMPATH’s new executive leadership is dealing with a host of difficult issues….

Read More

Dynacare, LabCorp, IMPATH, Visible Genetics, Abbott Labs

ACTIVITY AT DYNACARE HINTS AT POSSIBLE SALE, LABCORP MAY BE BUYER With Quest Diagnostics Incorporated snapping up independent lab companies right and left in recent months, the question asked by many is “Where’s Laboratory Corporation of America?” On …

Read More

Park City Solutions, DIANON, IMPATH American Med Labs, Cytyc, TriPath Imaging

PARK CITY SOLUTIONS AND AMERICAN MEDICAL LABS CREATE STRATEGIC PACT TWO COMPANIES FINANCED by GTCR Golder Rauner, LLC, the private equity firm based in Chicago, announced a strategic relationship. Park City Solutions, Inc. of Park City, Utah and Ame…

Read More

Developing Technology Expected To Fuel Boom In Anatomic Pathology

CEO SUMMARY: Established demographic trends point to a coming boom in the demand for anatomic pathology services. Greater number s of senior citizens, living longer lives, will raise the number of cancer cases diagnosed annually in the United States. New diagnostic technology will increas…

Read More

“Value Added” Services Essential to Success

ONE ELEMENT COMMON TO SUCCESSFUL LABORATORY ORGANIZATIONS of the future will be the ability to both understand the concept of “value added” services and to offer such services to customers. At its core, value added is an essential business strategy. There are many ways to define “value added.…

Read More

IMPATH Creates Its Brand Of Value-Added Pathology

CEO SUMMARY: IMPATH Inc. is a pathology company with an interesting twist. It doesn’t compete directly with community hospital-based pathologists like some national AP providers. Instead, it offers AP services which supplement the capabilities of the local pathologist. The formula must …

Read More

IMPATH Points Pathology Toward a Winning Future

CEO SUMMARY: Pathology is about to undergo a market transformation similar to radiology. As clinicians insist on more precise diagnostic and prognostic information about their patients, pathologists will have a perfect opportunity to reposition themselves as essential partners with the re…

Read More

“Disease Management” Firms, Niche Labs Release Financials

Two DISEASE MANAGEMENT FIRMS enjoyed strong revenue growth during the first quarter of 1998. UroCor, Inc. and Impath Inc. posted revenue increases of 31% and 49%, respectively, over first quarter 1997. UroCor is the disease management company which serves urologists…

Read More

“March 23, 1998 Intelligence: Late Breaking Lab News”

Independent physician association (IPA) executives gathered in Orlando two weeks ago for the annual meeting of TIPAAA, The IPA Association of America. Because IPAs play an increasing role in contracting for laboratory services, THE DARK REPORT was in attendance to learn more about th…

Read More

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.